Table of Contents

Chapter 1 Methodology and Scope
1.1 Segment Market Scope
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
Chapter 2 Methodology
2.1 Research Methodology
2.1.1 Information Procurement
2.2 Information or Data Analysis
2.3 Market Formulation & Validation
2.4 Model Details
2.4.1 Commodity Flow Analysis (Model 1)
2.4.1.1 Approach 1: Commodity Flow Approach
2.5 List of Secondary Sources
2.6 List of Primary Sources
2.7 List of Abbreviations
2.8 Objectives
2.8.1 Objective 1:
2.8.2 Objective 2:
Chapter 3 Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.3 Competitive Insights
Chapter 4 Market Variables, Trends & Scope
4.1 Market Lineage Outlook
4.1.1 Parent market outlook
4.1.2 Related/ancillary market outlook
4.2 Market Segmentation
4.3 Business Segment Trends
4.3.1 Product segment analysis
4.3.2 Application segment analysis
4.3.3 End-use segment analysis
4.3.4 Regional segment analysis
4.4 Product Pipeline
4.5 User perspective analysis
4.5.1.1 Consumer Behavior Analysis
4.5.1.2 Market Influencer Analysis
4.6 Regulatory Framework
4.6.1 Reimbursement framework
4.6.2 Standards & Compliances
4.7 Market Variable Analysis
4.7.1 Market driver analysis
4.7.1.1 Increasing geriatric population
4.7.1.2 Rising prevalence of chronic conditions
4.7.1.2.1 Neurological disorders
4.7.1.2.2 Cancer
4.7.1.3 Cost effective treatment
4.7.1.4 Rising demand of wireless and portable systems
4.7.1.5 Technological advancement
4.7.2 Market restraint analysis
4.7.2.1 Data security concerns
4.7.2.2 Lack of supportive reimbursement coverage
4.7.3 Industry Challenges
4.7.3.1 Interoperability of data
4.7.3.2 Digital literacy
4.8 Business Environment Analysis tools
4.8.1 SWOT Analysis, by PEST
4.8.1.1 Political & legal Landscape
4.8.1.1.1 Strength
4.8.1.1.2 Weakness
4.8.1.1.3 Opportunity
4.8.1.1.4 Threat
4.8.1.2 Economical Landscape
4.8.1.2.1 Strength
4.8.1.2.2 Weakness
4.8.1.2.3 Opportunity
4.8.1.2.4 Threat
4.8.1.3 Social & Technology Landscape
4.8.1.3.1 Strength
4.8.1.3.2 Weakness
4.8.1.3.3 Opportunity
4.8.1.3.4 Threat
4.8.2 Porter’s five forces analysis
4.8.2.1 Bargaining Power of Supplier
4.8.2.2 Bargaining Power of Buyer
4.8.2.3 Threat of Substitution
4.8.2.4 Threat of new entrant
4.8.2.5 Competitive rivalry
4.8.3 Major Deals & Strategic Alliances Analysis
4.8.4 COVID-19 Impact Analysis
Chapter 5 Product Estimates And Trend Analysis
5.1 Definition and Scope
5.2 Remote patient monitoring system market: Product Movement Analysis
5.3 Vital Sign Monitors
5.3.1 Vital Signs Monitor Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.2 Blood pressure monitor
5.3.2.1 Blood Pressure Monitor Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.3 Pulse oximeter
5.3.3.1 Pulse Oximeter Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.4 Heart rate monitor (ECG)
5.3.4.1 Heart Rate Monitor (ECG) Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.5 Temperature monitor
5.3.5.1 Temperature Monitor Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.6 Respiratory rate monitor
5.3.6.1 Respiratory Rate Monitors Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.7 Brain monitor (EEG)
5.3.7.1 Brain Monitors Market Estimates And Forecasts, 2018-2030 (USD Million)
5.4 Special monitors
5.4.1 Special Monitors Market Estimates And Forecasts, 2018-2030 (USD Million)
5.4.2 Anesthesia monitor
5.4.2.1 Anesthesia Monitor Market Estimates And Forecasts, 2018-2030 (USD Million)
5.4.3 Blood glucose monitor
5.4.3.1 Blood Glucose Monitor Market Estimates And Forecasts, 2018-2030 (USD Million)
5.4.4 Cardiac rhythm monitor
5.4.4.1 Cardiac Rhythm Monitor Market Estimates And Forecasts, 2018-2030 (USD Million)
5.4.5 Respiratory monitor
5.4.5.1 Respiratory Monitor Market Estimates And Forecasts, 2018-2030 (USD Million)
5.4.5.2 Spirometers
5.4.5.2.1 Spirometers market ESTIMATES AND FORECASTS, 2018-2030 (USD Million)
5.4.5.3 Capnographs
5.4.5.3.1 Capnographs market ESTIMATES AND FORECASTS, 2018-2030 (USD Million)
5.4.6 Fetal heart monitor
5.4.6.1 Fetal Heart Monitor Market Estimates And Forecasts, 2018-2030 (USD Million)
5.4.7 Prothrombin monitor
5.4.7.1 Prothrombin Monitor Market Estimates And Forecasts, 2018-2030 (USD Million)
5.4.8 Multi Parameter monitor
5.4.8.1 Multi Parameter Monitor Market Estimates And Forecasts, 2018-2030 (USD Million)
5.4.9 Others
5.4.9.1 Others Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 6 Application Estimates And Trend Analysis
6.1 Definition and Scope
6.2 Remote patient monitoring system market: Application Movement Analysis
6.3 Cancer
6.3.1 Cancer Market Estimates And Forecasts, 2018-2030 (USD Million)
6.4 Cardiovascular Diseases
6.4.1 Cardiovascular Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
6.5 Diabetes
6.5.1 Diabetes Market Estimates And Forecasts, 2018-2030 (USD Million)
6.6 Sleep Disorders
6.6.1 Sleep Disorders Market Estimates And Forecasts, 2018-2030 (USD Million)
6.7 Weight Management and Fitness Monitoring
6.7.1 Weight Management and Fitness Monitoring Market Estimates And Forecasts, 2018-2030 (USD Million)
6.8 Bronchitis
6.8.1 Bronchitis Market Estimates And Forecasts, 2018-2030 (USD Million)
6.9 Infections
6.9.1 Infections Market Estimates And Forecasts, 2018-2030 (USD Million)
6.9.1.1 Eye Infections Market Estimates And Forecasts, 2018-2030 (USD Million)
6.9.1.2 Sinus Infections Market Estimates And Forecasts, 2018-2030 (USD Million)
6.9.1.3 Strep Throats Market Estimates And Forecasts, 2018-2030 (USD Million)
6.10 Virus
6.10.1 Virus market Estimates And Forecasts, 2018-2030 (USD Million)
6.11 Dehydration
6.11.1 Dehydration Market Estimates And Forecasts, 2018-2030 (USD Million)
6.12 Hypertension
6.12.1 Hypertension Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 7 End-use Estimates And Trend Analysis
7.1 Definition and Scope
7.2 Remote Patient Monitoring System Market: End-Use Movement Analysis
7.3 Hospital-based Patients
7.3.1 Hospital-based patients market estimates and forecasts, 2018-2030 (USD Million)
7.4 Ambulatory Patients
7.4.1 ambulatory patients market estimates and forecasts, 2018-2030 (USD Million)
7.5 Home Healthcare
7.5.1 home healthcare market estimates and forecasts, 2018-2030 (USD Million)
Chapter 8 Regional Estimates And Trend Analysis
8.1 Regional Market Snapshot
8.2 SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
8.2.1 North America
8.2.2 Europe
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East & Africa
8.3 Remote patient monitoring system Market Share by Region, 2022& 2030
8.4 North America
8.4.1 North America Remote patient monitoring system market estimates and forecasts, 2018- 2030 (USD Million)
8.4.2 U.S.
8.4.2.1 U.S. Remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.4.3 Canada
8.4.3.1 Canada Remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.5 Europe
8.5.1 Europe Remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.5.2 U.K.
8.5.2.1 U.K. Remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.5.3 Germany
8.5.3.1 Germany Remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.5.4 France
8.5.4.1 France Remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.5.5 Italy
8.5.5.1 Italy Remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.5.6 Spain
8.5.6.1 Spain Remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.5.7 Sweden
8.5.7.1 Sweden Remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.5.8 Denmark
8.5.8.1 Denmark Remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.5.9 Norway
8.5.9.1 Norway Remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.6 Asia Pacific
8.6.1 Asia Pacific Remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.6.2 Japan
8.6.2.1 Japan remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.6.3 China
8.6.3.1 China remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.6.4 India
8.6.4.1 India remote patient monitoring system market estimates and forecasts, 2017 -2030 (USD Million)
8.6.5 Thailand
8.6.5.1 Thailand remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.6.6 South Korea
8.6.6.1 South Korea remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.6.7 Australia
8.6.7.1 Australia remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.7 Latin America
8.7.1 Latin America remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.7.2 Brazil
8.7.2.1 Brazil remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.7.3 Mexico
8.7.3.1 Mexico remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.7.4 Argentina
8.7.4.1 Argentina remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.8 Middle East & Africa (MEA)
8.8.1 MEA remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.8.2 South Africa
8.8.2.1 South Africa remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.8.3 Saudi Arabia
8.8.3.1 Saudi Arabia remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.8.4 UAE
8.8.4.1 UAE remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
8.8.5 Kuwait
8.8.5.1 Kuwait remote patient monitoring system market estimates and forecasts, 2018 – 2030 (USD Million)
Chapter 9 Competitive Analysis
9.1 Recent Development by Key Market Players
9.2 Company/Competition Categorization (Key Innovators, Market Leaders)
9.2.1 Participant Categorization
9.3 Remote patient monitoring system -market share analysis
9.4 Company Profiles
9.4.1 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
9.4.1.1 Company Overview
9.4.1.2 Financial Performance
9.4.1.3 Product Benchmarking
9.4.1.4 Strategic Initiatives
9.4.2 Nihon Kohden Corporation.
9.4.2.1 Company Overview
9.4.2.2 Financial Performance
9.4.2.3 Product Benchmarking
9.4.2.4 Strategic Initiatives
9.4.3 Omron Corporation.
9.4.3.1 Company Overview
9.4.3.2 Financial Performance
9.4.3.3 Product Benchmarking
9.4.3.4 Strategic Initiatives
9.4.4 OSI Systems, Inc.
9.4.4.1 Company Overview
9.4.4.2 Financial Performance
9.4.4.3 Product Benchmarking
9.4.4.4 Strategic Initiatives
9.4.5 Koninklijke Philips N.V.
9.4.5.1 Company Overview
9.4.5.2 Financial Performance
9.4.5.3 Product Benchmarking
9.4.5.4 Strategic Initiatives
9.4.6 F. Hoffmann-La Roche Ltd.
9.4.6.1 Company Overview
9.4.6.2 Financial Performance
9.4.6.3 Product Benchmarking
9.4.6.4 Strategic Initiatives
9.4.7 Welch Allyn.
9.4.7.1 Company Overview
9.4.7.2 Financial Performance
9.4.7.3 Product Benchmarking
9.4.7.4 Strategic Initiatives
9.4.8 ALTEN Calsoft Labs.
9.4.8.1 Company Overview
9.4.8.2 Financial Performance
9.4.8.3 Product Benchmarking
9.4.8.4 Strategic Initiatives
9.4.9 Smiths Medical.
9.4.9.1 Company overview
9.4.9.2 Financial Performance
9.4.9.3 Product Benchmarking
9.4.9.4 Strategic Initiatives
9.4.10 Abbott
9.4.10.1 Company Overview
9.4.10.2 Financial Performance
9.4.10.3 Product Benchmarking
9.4.10.4 Strategic Initiatives
9.4.11 American TeleCare
9.4.11.1 Company Overview
9.4.11.2 Financial Performance
9.4.11.3 Product Benchmarking
9.4.11.4 Strategic Initiatives
9.4.12 Boston Scientific Corporation
9.4.12.1 Company Overview
9.4.12.2 Financial Performance
9.4.12.3 Product Benchmarking
9.4.12.4 Strategic Initiatives
9.4.13 Dräger Medical
9.4.13.1 Company Overview
9.4.13.2 Financial Performance
9.4.13.3 Product Benchmarking
9.4.13.4 Strategic Initiatives
9.4.14 GE Healthcare
9.4.14.1 Company Overview
9.4.14.2 Financial Performance
9.4.14.3 Product Benchmarking
9.4.14.4 Strategic Initiatives
9.4.15 Honeywell Life Care Solutions
9.4.15.1 Company Overview
9.4.15.2 Financial Performance
9.4.15.3 Product Benchmarking
9.4.15.4 Strategic Initiatives
9.4.16 Johnson & Johnson Services, Inc.
9.4.16.1 Company Overview
9.4.16.2 Financial Performance
9.4.16.3 Product Benchmarking
9.4.16.4 Strategic Initiatives
9.4.17 LifeWatch
9.4.17.1 Company Overview
9.4.17.2 Financial Performance
9.4.17.3 Product Benchmarking
9.4.17.4 Strategic Initiatives
9.4.18 Masimo
9.4.18.1 Company Overview
9.4.18.2 Financial Performance
9.4.18.3 Product Benchmarking
9.4.18.4 Strategic Initiatives
9.4.19 Medtronic Plc
9.4.19.1 Company Overview
9.4.19.2 Financial Performance
9.4.19.3 Product Benchmarking
9.4.19.4 Strategic Initiatives